Health Policy & Advocacy
Basic InformationMore InformationLatest News
Red Cross Needs Type O Blood to Ease ShortageLess Pain, More Car Crashes: Legalized Marijuana a Mixed BagPolitical Controversies Could Fuel Bullying of LGBT Youth: StudyCBD -- It's Everywhere, But Does It Work?Brief EMS Training Saves Lives After Brain InjuryU.S. Improves Emergency Readiness, but Gaps PersistSlowing Climate Change Could Cut Health Costs, Save MoneyDispensing Opioid Antidote Without a Prescription Might Save LivesNot Just Opioids: Deaths Tied to Cocaine, Meth Are Soaring, TooMost Americans Hit Hard by Medical BillsYour Virtual Doctor Will 'See' You NowHigh Measles Rates Mean Kids, Adults Need Proper Vaccination: CDCMany Drivers Testing Positive for Marijuana, Even With Kids in CarMedicaid Could Save $2.6 Billion a Year With Dip in SmokingFDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in WomenAnother Cost of the Opioid Epidemic: Billions of Dollars in Lost TaxesHealth Tip: Using an AEDNurse Practitioners Often Restricted From Prescribing Opioid TreatmentsForested Counties Have Lower Medicare Costs, Study FindsSimple CPR Doubles Survival OddsUninsured Get Short Shrift on Hospital StaysSpecial Bag Helps Patients Get Rid of Unused OpioidsHealth Tip: Responsibilities of Non-VaccinationDo Doctors Hounded by Malpractice Claims Just Shift Their Practice Elsewhere?Bans on Texting While Behind the Wheel Making Roads SaferColorado Sees Spike in ER Visits After Pot Made LegalMajor Medical Groups Call for Soda TaxesCould the U.S. Mail Deliver Better Colon Cancer Screening Rates?Opioid Rxs Decreasing, But Not for All DoctorsAfter Chinese Infant Gene-Editing Scandal, U.S. Health Officials Join Call for a BanAre 'Inactive' Ingredients in Your Drugs Really So Harmless?Need to Be Vaccinated? Try Your Local PharmacyBystanders Key to Cutting Cardiac Arrest DeathsMany Black Americans Live in Trauma Care 'Deserts'FDA Issues Asbestos Warning About Some Claire's Cosmetic ProductsFDA to Crack Down on Retailers That Keep Selling Tobacco to KidsBlood Donation by Teen Girls May Raise Anemia RiskNurses' Long Hours, Moonlighting Could Pose Patient Safety RiskBerkeley's Efforts Suggest Soda Taxes Do Cut Soda SalesOpioid Overdose Deaths Quadruple, Centered in 8 StatesPayments for Research Can Lead to Lies: StudyFDA Aims to Strengthen Sunscreen RulesAre Primary Care Doctors Prepared to Discuss Cancer Treatment?FDA Fell Short in Preventing Fentanyl Abuse Crisis, Report ClaimsPrimary Care Doctors Help Boost Life Spans, But More Are NeededMore Car Crashes Tied to Drivers High on OpioidsPoor Whites Bear the Brunt of U.S. Opioid Crisis, Studies FindFDA to Tighten Oversight of SupplementsAs U.S. Measles Outbreaks Spread, Why Does 'Anti-Vax' Movement Persist?Even Brief EMS Delay Can Cost Lives After Car Crash
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance

FDA Too Quick to Call BPA Chemical Safe, Health Experts Say

HealthDay News
by By Dennis ThompsonHealthDay Reporter
Updated: Oct 23rd 2018

new article illustration

TUESDAY, Oct. 23, 2018 (HealthDay News) -- The U.S. Food and Drug Administration "jumped the gun" when it declared the chemical BPA safe for consumers earlier this year, experts from the Endocrine Society claimed Tuesday.

The FDA asserted in February that its "initial review supports our determination that currently authorized uses of BPA continue to be safe for consumers."

But the FDA made that statement without reviewing pending evidence from ongoing studies being conducted outside the agency, said Heather Patisaul, a professor with North Carolina State University's department of biological sciences.

Further, the agency even shrugged off its own data showing that low levels of BPA could increase risk of breast and prostate cancer, said Laura Vandenberg, an associate professor with the University of Massachusetts Amherst School of Public Health and Health Sciences.

"There are serious effects that were observed in the FDA core study, even in the groups that were exposed only to low doses of BPA," Vandenberg said. "Unfortunately, these effects seem to be dismissed by the FDA, often because they aren't observed at high doses."

The FDA did not respond to a request from HealthDay for comment.

The FDA study had been designed as a groundbreaking collaboration between federal regulators and academic scientists.

In the study, researchers force-fed BPA to lab rats at varying doses and for varied amounts of time, out to two years.

The effort was aimed at clearing up safety concerns regarding BPA, a chemical used to make plastic containers and the lining of food cans. BPA mimics the hormone estrogen in the body, and has been linked to reproductive, behavior and metabolic disorders, Vandenberg said.

But the final report, which integrates the FDA data with results from academic studies, won't be released until fall of 2019, said Patisaul. She is one of the academic researchers involved in the final report. Some of the academic studies are still undergoing peer review.

Despite this, the FDA issued a statement months ago based solely on its own data, which it referred to as "an important step for this consortium."

But, Patisaul explained, "Now we're in the very critical phase where we have to take all of that information, put all of that data together, and come up with a conclusion for how BPA impacts our bodies. That will involve not only the FDA's core study data, but all of the data from the independent investigators."

So, she added, "that's why there has been concern from the Endocrine Study and others that FDA is jumping the gun a little bit in its conclusion that BPA in food packaging is safe, because the data has not yet been integrated."

The FDA statement did note that the integrated report would be released in the future, but Patisaul said that by issuing the statement, the agency had essentially established a firm position in favor of BPA's safety.

"The FDA has put a stake in the ground. They have said BPA is safe. And they are very reluctant to back away from that stake, because doing so requires them to admit, essentially capitulate, that they got it wrong the first time," Patisaul said.

However, even within the FDA's own data there's reason to doubt BPA's safety, Vandenberg said.

The FDA data shows that at low doses, BPA increased the incidence of breast cancer, prostate inflammation and kidney disease in lab rats, she explained.

For example, more than 20 percent of rats exposed to a low dose of BPA developed breast cancer, and about 45 percent had increased prostate inflammation at a similarly low dose, according to Vandenberg.

The FDA might have disregarded these findings because there wasn't a clear dose-response relationship, in that the health risk from BPA failed to increase with the level of the dose, she noted.

But substances that affect the hormone system often only show effects at low doses (where the body mistakes the substance for an actual hormone) and high doses (where levels become toxic), she said.

"The reality is not a linear relationship between dose and effect, but a U-shaped relationship," Vandenberg explained.

Patisaul said that consumers worried about BPA safety can protect themselves by using less plastic, instead storing food in glass containers. They also can avoid handling thermal paper receipts or microwaving food in plastic containers.

"If you're really worried you can avoid canned foods, particularly things like tomatoes that are acidic and react with the lining," Patisaul suggested.

More information

The Mayo Clinic has more about BPA.


Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.


powered by centersite dot net